Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant threats » significant threat (Expand Search), significant effects (Expand Search), significant health (Expand Search)
threats decrease » greatest decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant threats » significant threat (Expand Search), significant effects (Expand Search), significant health (Expand Search)
threats decrease » greatest decrease (Expand Search), greater decrease (Expand Search)
-
3481
Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3.
Published 2024Subjects: -
3482
-
3483
-
3484
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3485
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3486
-
3487
-
3488
-
3489
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3490
-
3491
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3492
-
3493
-
3494
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3495
-
3496
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3497
-
3498
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3499
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3500